We have one key focus: To contribute towards the global effort to combat antibiotic resistance. Allecra’s contribution is to develop new treatments which overcome emerging resistance mechanisms, thereby saving lives of patients whose infections may otherwise be inadequately treated


Our mission is to develop new treatments that save lives by overcoming antibiotic resistance

The Team

Each team member has on average 20+ years’ experience in researching, developing and commercializing novel pharmaceuticals such as antibiotics

Investor Relations

Find the latest funding information here


The World Health Organization
Find out more

Centers for Disease Control
Find out more

European Commission
Find out more

Antibiotic Resistance

Antibiotic resistance is one of the 21st Century’s greatest healthcare challenges


Allecra has a new compound in development that targets resistant Gram-negative bacterial infections